As Lilly rivalry heats up, Novo CEO details strategy for new Wegovy launches
By Maggie Fick and Jacob Gronholt-Pedersen LONDON/COPENHAGEN (Reuters) -Novo Nordisk
lilly
Eli Lilly Launches New Obesity Drug Zepbound in U.S. Pharmacies
INDIANAPOLIS, IN – Pharmaceutical giant Eli Lilly announced the availability
Retail investors crowd into Eli Lilly after weight-loss drug approval
By Bhanvi Satija and Amruta Khandekar (Reuters) – Retail flows
Novo Nordisk, Lilly see insatiable demand for weight-loss drugs
By Maggie Fick and Bhanvi Satija (Reuters) – Novo Nordisk
Eli Lilly to buy Sigilon Therapeutics to expand diabetes treatments
(Reuters) – Eli Lilly and Co said on Thursday it
Lilly experimental ‘triple G’ obesity drug leads to 24.2% weight loss in trial
By Deena Beasley (Reuters) -Eli Lilly on Monday said a
Experimental Lilly pill, Mounjaro both lead to 15% weight loss in clinical trials
By Deena Beasley (Reuters) -In a mid-stage trial, the highest
Eli Lilly to invest additional $1.6 billion in 2 new plants
(Reuters) – Eli Lilly and Co said on Monday it
Fake account shows ‘challenges’ with Twitter – Lilly CEO (Nov 16)
(Removes reference to Ricks’ comment on apology from Lilly in
Analysis-Alzheimer’s drug breakthrough big boost for Roche, Eli Lilly
By Natalie Grover LONDON (Reuters) – The results of a